Viewing Study NCT00086216


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2026-04-26 @ 9:37 AM
Study NCT ID: NCT00086216
Status: COMPLETED
Last Update Posted: 2007-12-21
First Post: 2004-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma
Sponsor: Callisto Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple myeloma View